113 related articles for article (PubMed ID: 2552211)
1. [Carbohydrate antigens in pleural effusion from patients with lung cancer].
Hiratani K; Sakito O; Mukae H; Morikawa N; Kadota J; Fukushima K; Komori K; Hirota M; Hara K
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jun; 27(6):673-8. PubMed ID: 2552211
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of CYFRA 21-1 in malignant and benign pleural effusions.
Toumbis M; Rasidakis A; Passalidou E; Kalomenidis J; Alchanatis M; Orphanidou D; Jordanoglou J
Anticancer Res; 1996; 16(4A):2101-4. PubMed ID: 8712750
[TBL] [Abstract][Full Text] [Related]
3. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma.
Kohno N; Akiyama M; Kyoizumi S; Hakoda M; Kobuke K; Yamakido M
Jpn J Clin Oncol; 1988 Sep; 18(3):203-16. PubMed ID: 3411786
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic value of pleural effusion carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific-enolase in patients with lung cancer].
Fujii M; Kiura K; Kamei H; Segawa Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1988 May; 26(5):519-23. PubMed ID: 2852270
[No Abstract] [Full Text] [Related]
5. [A case of lung cancer producing CA19-9 and amylase].
Takano Y; Iwakiri T; Ichiyasu Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Feb; 31(2):267-70. PubMed ID: 7685838
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of various tumor markers in pleural effusion and in the serum].
Jibiki K; Abe Y; Takeda M; Iwachika C; Odagiri E; Demura R; Demura H
Gan No Rinsho; 1989 Aug; 35(9):991-8. PubMed ID: 2769951
[TBL] [Abstract][Full Text] [Related]
7. [Pathological study of carbohydrate antigens in human lung cancer with monoclonal antibodies].
Kimura S; Saitou D; Kimura K; Yakata M; Hakomori S
Rinsho Byori; 1991 Jul; 39(7):765-72. PubMed ID: 1656116
[TBL] [Abstract][Full Text] [Related]
8. [Tumor marker in lung cancer].
Shijubo N; Abe S
Kokyu To Junkan; 1993 Jun; 41(6):551-5. PubMed ID: 7687790
[No Abstract] [Full Text] [Related]
9. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
Li CS; Cheng BC; Ge W; Gao JF
Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the major sialyl-Lex-positive mucins present in colon, colon carcinoma, and sera of patients with colorectal cancer.
Hanski C; Hanski ML; Zimmer T; Ogorek D; Devine P; Riecken EO
Cancer Res; 1995 Feb; 55(4):928-33. PubMed ID: 7850810
[TBL] [Abstract][Full Text] [Related]
11. [Measurement of CA19-9 in bronchial lavage fluid from patients with lung cancer].
Asada K; Ogushi F; Tani K; Kawaji K; Nakahira S; Yasuoka S; Ogura T
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Sep; 30(9):1682-6. PubMed ID: 1447844
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies to human squamous cell carcinoma of the lung and their application to tumor diagnosis.
Kyoizumi S; Akiyama M; Kouno N; Kobuke K; Hakoda M; Jones SL; Yamakido M
Cancer Res; 1985 Jul; 45(7):3274-81. PubMed ID: 4005855
[TBL] [Abstract][Full Text] [Related]
13. [The diagnostic values of CA242 combining other tumor markers for lung cancer].
Zhang S; Ma Y; Yang X
Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):271-3. PubMed ID: 11775851
[TBL] [Abstract][Full Text] [Related]
14. [Availability of the carbohydrate antigen (sialylated Lewis) as a tumor marker in pleural effusion].
Hiratani K; Hirota M; Fukushima K; Tomonaga A; Saito A; Hara K; Fujiwara K
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2678-80. PubMed ID: 3017233
[No Abstract] [Full Text] [Related]
15. [Clinical evaluation and tissue distribution of CA125 in patients with pleural effusion].
Tomita Y
Igaku Kenkyu; 1989 Nov; 59(3):90-6. PubMed ID: 2639592
[TBL] [Abstract][Full Text] [Related]
16. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialyl-fucosyl type 2 chain polylactosamine.
Kannagi R; Fukushi Y; Tachikawa T; Noda A; Shin S; Shigeta K; Hiraiwa N; Fukuda Y; Inamoto T; Hakomori S
Cancer Res; 1986 May; 46(5):2619-26. PubMed ID: 3008996
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions.
Miédougé M; Rouzaud P; Salama G; Pujazon MC; Vincent C; Mauduyt MA; Reyre J; Carles P; Serre G
Br J Cancer; 1999 Nov; 81(6):1059-65. PubMed ID: 10576665
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
Klech H; Rona G; Hutter C; Bayer PM; Kummer F
Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
[TBL] [Abstract][Full Text] [Related]
19. Lung carcinoma-reactive antibodies isolated from tumor tissues and pleural effusions of lung cancer patients.
Paluch E; Ioachim HL
J Natl Cancer Inst; 1978 Aug; 61(2):319-25. PubMed ID: 79656
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen (CEA) levels in pleural effusions and sera of lung cancer patients.
Ogushi F; Fukuoka M; Takada M; Tamai S; Sakai N; Negoro S; Okunaka N; Sone S; Tsubura E
Jpn J Clin Oncol; 1984 Sep; 14(3):321-7. PubMed ID: 6090732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
